PBMs Must Prepare for Revival of Drug Price Transparency Requirements
-
Mar 13, 2025
While a previous effort to force the disclosure of net drug prices was scuttled amid legal challenges, President Donald Trump recently made it clear that he hopes to revisit the issue amid a renewed push for health care price transparency.
“There’s no more hope that this will go away,” says Chris O’Dell, senior vice president of market solutions with Turquoise Health, a company that cleans and aggregates pricing data from hospitals and health plans. “It’s going to happen, so get ready for it, research it, comment on it, and do what you can to prepare.”
Read more
© 2025 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters